Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. extrulub

ExtruLub

Commercialisation of Advanced Extrusion Technologies Delivering Disruptive Innovation for the Next Generation of Catheter Based Medical Devices.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 ExtruLub project word cloud

Explore the words cloud of the ExtruLub project. It provides you a very rough idea of what is the project "ExtruLub" about.

polymer    advancing    5bn    protective    23    sits    generation    customers    science    whilst    surface    business    manufacturer    realise    medical    genuine    site    economic    containment    skilled    initial    resins    command    enhancement    thrombogenic    innovative    mn    alternatives    21    drugs    savings    coloplast    grow    batch    company    safeguarding    markets    extrulub    measured    42    combined    market    world    ambition    51    30    15    2020    device    model    globally    chemistry    reducing    extrusion    564mn    surfaces    full    first    harnessing    anti    eg    170mn    supply    patient    oem    gain    customer    share    preferred    revenue    international    profile    13    replace    sub    functional    diania    boston    safety    medtronic    attaining    materials    catheter    technologies    facilitates    differentiation    reduce    disruptive    scientific    urology    oems    applicable    3mn    alone    cardiology    original    ca    perspective    realising    engineering    generate    antimicrobial    assists    equating    independent    friction    showed    hollister    function    global    gross    manufacturing    margins    lean    line    jobs    core    demonstrated   

Project "ExtruLub" data sheet

The following table provides information about the project.

Coordinator		 DIANIA TECHNOLOGIES LIMITED 

Organization address
address: UNIT 120 NUIG BUSINESS INNOVATION CENTRE UPPER NEWCASTLE
city: GALWAY
postcode: H91 Y682
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Ireland [IE]
 Project website http://linkedin.com/company/DiaNia-Technologies
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIANIA TECHNOLOGIES LIMITED IE (GALWAY) coordinator 50˙000.00

Map

 Project objective

ExtruLub is an innovative, disruptive extrusion technology applicable across a range of medical polymer resins, which has the ability to change the surface of a catheter without affecting core device properties. The technology sits in the component sub-supply global market with an initial value of €564mn applicable across all catheter markets (combined value of $42.5bn globally by 2020). From a functional perspective, ExtruLub has the ability to reduce surface friction, generate protective antimicrobial & anti-thrombogenic surfaces & deliver site specific drugs all whilst reducing catheter profile. This enhancement of catheter function assists in safeguarding patient safety & will command genuine product differentiation for the original equipment manufacturer (OEM) of the end device, enabling them to gain market share.From an economic perspective it facilitates a change from lean to batch manufacturing realising cost containment for the target customer.Taking the cardiology sector as an example, an independent study demonstrated ExtruLub would reduce costs for the OEM (eg Boston Scientific, Medtronic etc.) by 51% realising savings of ca. €3mn p.a in one product. In the urology sector, the measured impact showed increased gross margins of ca.13% on one product line alone enabling €21.5 mn p.a. savings for potential customers like Hollister, Coloplast etc. DiaNia Technologies ambition is to grow into a world leading, international technology company, realising market share through disruptive technologies.Our initial goal is to replace current ExtruLub alternatives attaining a 30% market share with the friction product, equating to €170mn in full production.Harnessing advanced polymer chemistry through materials science and engineering has the potential to realise €23.3mn in revenue & 15 new, highly skilled jobs within the first 4 years through a business model preferred by OEMs.This disruptive technology is the key to advancing the next generation of medical devices.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXTRULUB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXTRULUB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

INFINITE (2015)

INnovative laser machine For INdustrial engravIng and 3d TExturing

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More  

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More